MedTrace Logo

Acute Changes in Bioimpedance During Cardiac Resynchronization Therapy

NCT03640000 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-08-21

No results posted yet for this study

Summary

This study aims at Optimizing measured parameters to reflect underlying pathology in dyssynchronous hearts. This is an experimental study in patients were bioimpedance measurements are performed during implantation.

Conditions

  • Heart Failure, Systolic

Interventions

DIAGNOSTIC_TEST

Impedance measurements in Cardiac Resynchronization therapy

Bioimpedance measurements

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Hans Henrik Odland, MD, PhD · Oslo University Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03640000 on ClinicalTrials.gov